Maria Luisa Ojeda Fernández

Istituto di Ricerche Farmacologiche Mario Negri

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (18)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (20)

Hellas Cena

University of Pavia

ITALY

View details

José Ramón González Juanatey

SPAIN

View details

Antonio J Quesada

Head of the Clinical Trials Coordination Unit

Centro Nacional de Investigaciones Cardiovasculares (CNIC)

SPAIN

View details

Licia Iacoviello

Professore ordinario

Università degli Studi di Roma La Sapienza

ITALY

View details

ELISABETTA DEJANA

Professor

Uppsala University

SWEDEN

View details

Damiano Baldassarre

Associate Professor

Università degli Studi di Roma Tor Vergata Facoltà di Medicina e Chirurgia

ITALY

View details

Matteo Bertini

Dirigente Medico, Professore di Cardiologia

Azienda Ospedaliero Universitaria di Ferrara Arcispedale Sant'Anna

ITALY

View details

Giuseppe Ferrante

Assistant Professor

Humanitas University

ITALY

View details

Antonio Portolés-Pérez

Profesor Titular Vinculado

Universidad Complutense de Madrid Facultad de Medicina

SPAIN

View details

Ginevra Torrigiani

University of Milano-Bicocca

ITALY

View details

Laura Comini

Istituti Clinici Scientifici Maugeri SpA IRCCS Lumezzane

ITALY

View details

Marco Gobbi

Head, Lab. Pharmacodynamics and Pharmacokinetics

Istituto di Ricerche Farmacologiche Mario Negri IRCCS

ITALY

View details

Eduardo Villacorta

University Hospital of Salamanca

SPAIN

View details

Javier Limeres Freire

Vall d'Hebron Institut de Recerca

SPAIN

View details

Luca V. C. Valenti

ITALY

View details

Mauro Tettamanti

Head of the Geriatric Epidemiology Laboratory

Istituto di Ricerche Farmacologiche Mario Negri

ITALY

View details

Jan Malik

Professor, teacher

Charles University, First Faculty of Medicine

CZECH REPUBLIC

View details

Guillermo Moreno

Assistant professor

Universidad Complutense de Madrid

SPAIN

View details

Gonzalo Pizarro

Chief of Department

SPAIN

View details

Alessandro Nobili

Istituto di Ricerche Farmacologiche Mario Negri

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Maria Luisa Ojeda Fernández

Research Interests

Explore related searches

Contact this professor

Articles (18)

Lights and Shadows of a Primary School-Based Nutrition Education Program in Italy: Insights from the LIVELY Project

Predictors of COVID-19 Readmission Among Patients Previously Hospitalized for SARS-CoV-2.

Risk of incident atrial fibrillation after COVID-19 infection: A systematic review and meta-analysis

Incidence and risk of arterial and venous thrombotic events in Systemic Lupus Erythematosus patients: a population-based study

LIVELY: MuLtidimensional school-based and family Involved interVentions, to promote a hEalthy and sustainable LifestYle for the childhood obesity primary prevention, a Study Protocol (Preprint)

Use of betablockers in post-myocardial infarction patients in a real-world setting.

Prevalence and Predictors of Post-Acute COVID-19 Symptoms in Italian Primary Care Patients.

UDCA treatment against COVID‐19: Do we have enough clinical evidence for drug repurposing?

Rationale and design of the CV-PREVITAL study: an Italian multiple cohort randomised controlled trial investigating innovative digital strategies in primary cardiovascular prevention

Impact of first and second/third wave of COVID-19 pandemic on post-acute cardiovascular outcomes in Lombardy.

Polypill Strategy in Secondary Cardiovascular Prevention

Metformin use is associated with a decrease in the risk of hospitalization and mortality in COVID‐19 patients with diabetes: A population‐based study in Lombardy

The impact of oral anticoagulant drugs for arterial thromboembolism in patients with cancer.

High-dose ivermectin for early treatment of COVID-19 (COVER study): a randomised, double-blind, multicentre, phase II, dose-finding, proof-of-concept clinical trial.

IGFBP7 and GDF-15, but not P1NP, are associated with cardiac alterations and 10-year outcome in an elderly community-based study.

SARS-CoV-2 Infection in Hereditary Hemorrhagic Telangiectasia Patients Suggests Less Clinical Impact Than in the General Population.

Propranolol for familial cerebral cavernous malformation (Treat_CCM): study protocol for a randomized controlled pilot trial

Circulating biomarkers and cardiac function over 3 years after chemotherapy with anthracyclines: the ICOS-ONE trial.

Collaborators (20)

Hellas Cena

José Ramón González Juanatey

Antonio J Quesada

Licia Iacoviello

ELISABETTA DEJANA

Damiano Baldassarre

Matteo Bertini

Giuseppe Ferrante

Antonio Portolés-Pérez

Ginevra Torrigiani

Laura Comini

Marco Gobbi

Eduardo Villacorta

Javier Limeres Freire

Luca V. C. Valenti

Mauro Tettamanti

Jan Malik

Guillermo Moreno

Gonzalo Pizarro

Alessandro Nobili

Make your next move.